Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 2 | 4 | ECONOMICS//POLITICAL SCIENCE//EDUCATION & EDUCATIONAL RESEARCH | 1996300 |
| 104 | 3 | LAW//FORDHAM LAW REVIEW//BUSINESS LAWYER | 75360 |
| 2357 | 2 | JOURNAL OF THE COPYRIGHT SOCIETY OF THE USA//LAW//IIC-INTERNATIONAL REVIEW OF INDUSTRIAL PROPERTY AND COPYRIGHT LAW | 4616 |
| 36017 | 1 | LIGHT SCHEDULE//PATHOPHYSIOLMINATO KU//TOXIC INTERACTION | 104 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | LIGHT SCHEDULE | authKW | 606097 | 2% | 100% | 2 |
| 2 | PATHOPHYSIOLMINATO KU | address | 404064 | 2% | 67% | 2 |
| 3 | TOXIC INTERACTION | authKW | 372978 | 4% | 31% | 4 |
| 4 | ADENOSINE TRIPHOSPHATASE CALCIUM SENSITIVITY | authKW | 303049 | 1% | 100% | 1 |
| 5 | APPLICATION SPECIFIC INTEGRATION CIRCUIT | authKW | 303049 | 1% | 100% | 1 |
| 6 | ARTIFICIAL ELECTRONIC NOSE | authKW | 303049 | 1% | 100% | 1 |
| 7 | CLENBUTEROL RECOMBINANT ERYTHROPOIETIN | authKW | 303049 | 1% | 100% | 1 |
| 8 | CLIN PHARM CLIN SCI PATHOPHYSIOL | address | 303049 | 1% | 100% | 1 |
| 9 | CONTAMINATION OF TISSUE ENGINEERED PRODUCTS | authKW | 303049 | 1% | 100% | 1 |
| 10 | EXPERIMENTAL ACUTE PULMONARY EMBOLISM | authKW | 303049 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Law | 879 | 17% | 0% | 18 |
| 2 | Information Science & Library Science | 751 | 13% | 0% | 14 |
| 3 | Andrology | 92 | 2% | 0% | 2 |
| 4 | Pharmacology & Pharmacy | 92 | 19% | 0% | 20 |
| 5 | Biotechnology & Applied Microbiology | 61 | 12% | 0% | 12 |
| 6 | Education, Scientific Disciplines | 32 | 3% | 0% | 3 |
| 7 | History & Philosophy of Science | 28 | 2% | 0% | 2 |
| 8 | Health Care Sciences & Services | 26 | 4% | 0% | 4 |
| 9 | Multidisciplinary Sciences | 24 | 3% | 0% | 3 |
| 10 | Medical Laboratory Technology | 11 | 2% | 0% | 2 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | PATHOPHYSIOLMINATO KU | 404064 | 2% | 67% | 2 |
| 2 | CLIN PHARM CLIN SCI PATHOPHYSIOL | 303049 | 1% | 100% | 1 |
| 3 | CLIN PHARM CLIN SCIMINATO KU | 151523 | 1% | 50% | 1 |
| 4 | OFF DEVICES BLOOD TISSUES | 33670 | 1% | 11% | 1 |
| 5 | CLIN PHARM CLIN SCI | 23765 | 2% | 4% | 2 |
| 6 | FPR UCLA CULTURE BRAIN DEV | 15151 | 1% | 5% | 1 |
| 7 | INT PUBL POLICY | 12120 | 1% | 4% | 1 |
| 8 | CLIN PHARM | 3027 | 9% | 0% | 9 |
| 9 | TOBACCO HLTH | 2384 | 1% | 1% | 1 |
| 10 | PHARMACEUT SCI MINATO KU | 2243 | 1% | 1% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | JOURNAL OF THE PATENT OFFICE SOCIETY | 135281 | 5% | 9% | 5 |
| 2 | JOURNAL OF THE PATENT AND TRADEMARK OFFICE SOCIETY | 25250 | 2% | 4% | 2 |
| 3 | BIOTECHNOLOGY & GENETIC ENGINEERING REVIEWS | 9912 | 3% | 1% | 3 |
| 4 | SCIENTIST | 7920 | 8% | 0% | 8 |
| 5 | BIOLOGICAL & PHARMACEUTICAL BULLETIN | 3464 | 10% | 0% | 10 |
| 6 | R&D MAGAZINE | 2046 | 1% | 1% | 1 |
| 7 | IIC-INTERNATIONAL REVIEW OF INDUSTRIAL PROPERTY AND COPYRIGHT LAW | 1750 | 1% | 1% | 1 |
| 8 | WASHINGTON LAW REVIEW | 1337 | 2% | 0% | 2 |
| 9 | ACTA BIOTECHNOLOGICA | 1330 | 2% | 0% | 2 |
| 10 | SOUTHERN CALIFORNIA LAW REVIEW | 979 | 2% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |